BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
9 | 539.80 | 452.00 | 5 |
25 | 452.00 | 455.00 | 5 |
2 | 450.20 | 458.00 | 5 |
1 | 450.00 | 459.00 | 1 |
4 | 447.20 | 0.00 | 53 |
1395 | Total | Total | 491 |
As on 11 Sep, 2023 | 09:24
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
9 | 539.80 | 452.00 | 5 |
25 | 452.00 | 455.00 | 5 |
2 | 450.20 | 458.00 | 5 |
1 | 450.00 | 459.00 | 1 |
4 | 447.20 | 0.00 | 53 |
1395 | Total | Total | 491 |
Open | 455.00 |
Previous Close | 450.20 |
Volume | 12,627.00 |
Value (Lacs) | 55.56 |
VWAP | 448.27 |
Beta |
High | 455.95 |
Low | 440.00 |
UC Limit | 540.20 |
LC Limit | 360.20 |
52 Week High | 457.00 |
52 Week Low | 5.00 |
TTM EPS See historical trend | 0.00 |
TTM PE See historical trend | -- (Average PE) |
P/B See historical trend | 88.18 (Average P/B) |
Face Value | 5.00 |
Mkt Cap (Rs. Cr.) | 3,988 |
Dividend Yield | 0.45 |
20D Avg Volume | 428,562 |
20D Avg Delivery(%) | 54.79 |
Sector PE | 17.21 |
Book Value Per Share | 4.99 |
*Delayed by 20 seconds.
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
Days | |
---|---|
5 | - - |
10 | - - |
20 | - - |
50 | - - |
100 | - - |
200 | - - |
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
Days |
---|
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Days |
---|
1 Week | --% | |
1 Month | --% | |
3 Months | --% | |
YTD | --% | |
1 Year | --% | |
3 Years | --% |
AARTIPHARM Consolidated March 2023 Net Sales at Rs 485.06 crore, up 5.38% Y-o-Y May 15 2023 09:05 AM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Qty 714011 | Price 255.33 | % Traded 0.79 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
Qty 7500 | Price 316.1 | % Traded 0.01 | Post Tnx Hold. 0.02% |
Qty 7500 | Price 330.77 | % Traded 0.01 | Post Tnx Hold. 0.01% |
Qty 214287 | Price 329.29 | % Traded 0.24 | Post Tnx Hold. 1.3% |
Qty 225000 | Price 315.91 | % Traded 0.25 | Post Tnx Hold. 1.06% |
Qty 150000 | Price 331.65 | % Traded 0.17 | Post Tnx Hold. 3.14% |
Qty 207000 | Price 315.91 | % Traded 0.23 | Post Tnx Hold. 2.97% |
*Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015
*Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Date | Agenda |
---|
Ex-Date | Type | Dividend (Rs) |
---|
Announcement Date | Ex-Bonus | Ratio |
---|
Ex-Split | Old FV | New FV |
---|
Ex-Right | Ratio | Premium |
---|
Date | Agenda |
---|
Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
---|---|---|---|---|---|---|---|---|---|---|
AARTIPHARM | 450.20 | 0.38 | 4,079.98 | - | 2.84 | 11.93 | - | 171 | 1,511 | 0.14 |
Poly Medicure | 1,388.10 | 1.16 | 13,321.68 | 61.97 | 12.24 | 14.43 | 56.77 | 177 | 1,115 | 0.12 |
Prevest Denpro | 477.10 | -1.85 | 572.66 | 35.55 | 7.87 | 21.58 | 0.92 | 15 | 49 | 0.00 |
Nureca | 342.10 | -2.44 | 342.11 | - | 1.75 | -4.31 | -65.35 | -8 | 111 | 0.00 |
Artemis Global | 51.00 | - | 337.56 | - | 2.13 | -0.07 | - | 0 | 0 | 0.00 |
Your feedback matters! Tell us what we got right and what we didn’t? Click here>